Patients Without Private or Commercial Insurance Are Less Likely to Be Worked up for Inflammatory Bowel Disease or Celiac Disease When They Present With Iron Deficiency Anemia and Diarrhea

Anyane-Yeboa Adjoa; Li Betty; Gulotta George; Yvellez Olivia V.; Rubin David T.

首页> 外文期刊>The American Journal of Gastroenterology >Patients Without Private or Commercial Insurance Are Less Likely to Be Worked up for Inflammatory Bowel Disease or Celiac Disease When They Present With Iron Deficiency Anemia and Diarrhea

【24h】

Patients Without Private or Commercial Insurance Are Less Likely to Be Worked up for Inflammatory Bowel Disease or Celiac Disease When They Present With Iron Deficiency Anemia and Diarrhea

机译：没有私人或商业保险的患者在患有缺铁性贫血和腹泻时，患有炎症性肠病或乳糜泻的可能性不太可能在炎症性肠病或乳糜泻。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American Journal of Gastroenterology》 |2018年第2期|共1页
作者
Anyane-Yeboa Adjoa; Li Betty; Gulotta George; Yvellez Olivia V.; Rubin David T.;
展开▼
作者单位

Univ Chicago Med Ctr Inflammatory Bowel Dis Chicago IL USA;

Univ Chicago Med Chicago IL USA;

Univ Chicago Med Ctr Inflammatory Bowel Dis Chicago IL USA;

Univ Chicago Med Ctr Inflammatory Bowel Dis Chicago IL USA;

Univ Chicago Med Ctr Inflammatory Bowel Dis Chicago IL USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Patients Without Private or Commercial Insurance Are Less Likely to Be Worked up for Inflammatory Bowel Disease or Celiac Disease When They Present With Iron Deficiency Anemia and Diarrhea [J] . Anyane-Yeboa Adjoa, Li Betty, Gulotta George, The American Journal of Gastroenterology . 2018,第Suppla2期

机译：没有私人或商业保险的患者在患有缺铁性贫血和腹泻时，患有炎症性肠病或乳糜泻的可能性不太可能在炎症性肠病或乳糜泻。
2. Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment [J] . Murawska Natalia, Fabisiak Adam, Fichna Jakub Inflammatory bowel diseases . 2016,第5期

机译：炎症性肠病患者慢性病和缺铁性贫血的贫血：病理生理学，诊断和治疗
3. Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark [J] . Pollock Richard F., Muduma Gorden Advances in therapy. . 2019,第8期

机译：响应：丹麦炎症肠病患者的铁异麦托糖苷1000对铁羧γ菌的经济评价
4. Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases [C] . J.-F. COLOMBEL, M. TORUNE Falk Symposium . 2007

机译：炎症性肠病患者的发病率增加了与免疫调节治疗有关的发病危险
5. Active Management of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease [D] . Lyons, Christopher. 2019

机译：炎症性肠病患者的粘性缺乏贫血的积极管理
6. Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis [O] . Jürgen Stein, Jennifer Scarlet Haas, Siew Hwa Ong, 2018

机译：在德国有和没有贫血的炎症性肠病和铁缺乏症患者口服铁剂和静脉铁剂治疗–现实证据分析
7. Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report [O] . Hale Akpinar, Mustafa Cetiner, Satish Keshav, 2017

机译：炎症肠病患者缺铁性贫血的诊断和治疗：铁缺乏贫血工作组共识报告

Patients Without Private or Commercial Insurance Are Less Likely to Be Worked up for Inflammatory Bowel Disease or Celiac Disease When They Present With Iron Deficiency Anemia and Diarrhea

著录项

相似文献

相关主题

期刊订阅